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Abstract
Backgound: The aims of this study were to evaluate the antimicrobial properties and synergistic effects of nano-titanium dioxide
(TiO2), nano- zinc oxide (ZnO) and two synthetic peptides (mastoparan-B, indolicidin) against drug-resistant strains of Pseudomonas
aeruginosa, Klebsiella pneumoniae, and Acinetobacter baumannii.
Methods: From March to August 2015, a total of 30 (10 each) isolates of the above bacteria were recovered from patients in the ICU of
two referral hospitals in Kerman, Iran. The sizes and purities of nano-TiO2, nano-ZnO were determined by scanning electron micro-
scope (SEM) and X-ray diffraction (XRD). Similarly, mass spectroscopy and HPLC were used for checking the genunity of the peptides.
Antibiotic sensitivity was determined by agar disk diffusion assay. The minimum inhibitory concentration (MIC) and minimum
bactericidal concentration (MBC) activities of nanometals and synthetic peptides were assessed by CLSI broth microdilution test.
Similarly, checkerboard and time-kill curve analysis were performed to determine the synergistic activities of these compounds.
Results: Mastoparan-B had potent toxicity to all isolates with an average MIC 4± 0.2 mg/L, while TiO2-NP had lowest antimicrobial
activity with MIC range 1280≥ ± 0.2 mg/L (P. aeruginosa growth was not inhibited by TiO2 and ZnO NPs). The bactericidal activity
against the isolates in descending order was mastoparan-B, indolicidin, nano ZnO, and nano TiO2, respectively. Further investigation
on synergism using fractional inhibitory concentration index (FIC) revealed that, nano-TiO2 and nano-ZnO combination had an
additive effect (FIC = 0.95± 0.1) on A. baumannii and K. pneumoniae strains, whereas, P. aeruginosa isolates were indifferent to this
combination (FIC≥ 2± 0.2). In contrast, mastoparan-B and indolicidin combination displayed broad synergistic effect (FIC = 0.5
± 0.1) on all the isolates and caused rapid killing of the organisms within 4 h of incubation.
Conclusions: Our results showed that the combination of mastoparan-B and indolicidin peptides is a suitable candidate for sub-
stitution of the antibiotics for topical treatment of infections caused by drug- resistant bacteria.
Keywords: Nano-Titanium Dioxide, Nano-Zinc Oxide, Mastoparan-B, Indolicidin, Synergism
1. Background
A. baumannii, K. pneumoniae, and P. aeruginosa are con-
sidered as a group of three pathogens responsible for the
most of multidrug-resistance (MDR) infections in hospi-
tal intensive care units (ICUs) around the globe and are
the major challenge for physicians due to lack of effective
treatment options especially in case of carbapenem resis-
tant strains (1, 2).
Zinc oxide (ZnO) and titanium dioxide (TiO2) nanopar-
ticles (NPs) are recently studied for their antimicrobial ac-
tivity against MDR isolates of methicillin-resistant Staphy-
lococcus aureus (MRSA) (3, 4). Reports suggested that cov-
ering of implants with nano-TiO2 stopped the adhesion
and growth of bacteria sp., such as Streptococcus mutants,
S. epidermis, and Escherichia coli, as well as preventing the
inflammation (5, 6). TiO2 NPs is effective against many
bacteria including spores of bacillus, which is the most
resistant organism known (7). Furthermore, ZnO NPs ex-
erted antibacterial activities against both Gram-positive
and Gram-negative bacteria, such as major foodborne bac-
terial pathogens like E. coli O157:H7, Salmonella sp., Liste-
ria monocytogenes, and S. aureus (8). It has been shown
that ZnO, Ag, and Ag doped titanium dioxide (Ag-TiO2)
had broad-spectrum antimicrobial activity against bacte-
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rial strains tested (9). SEM analysis revealed that admin-
istration of TiO2 NPs increases the bacterial cell volume
causes changes in the cell membrane permeability, which
led to cell lysis (10). ZnO NPs was relatively effective against
pathogens such as K. pneumonia, L. monocytogenes, and
Salmonella enteritidis (11).
Beside the nanometals, it has been reported that an-
tibacterial peptides such as mastoparan-B (MP-B) and in-
dolicidin are very effective for treating bacterial infections
(12). MP-B is an amphiphilic alpha-helical cationic antimi-
crobial peptide isolated from the venom of hornet Vespa
basalis (12). MP-B affects biological activity alone and in
combination with clinically used antibiotics against Acine-
tobacter baumannii (13). Its chemical structure allows elec-
trostatic interactions between the positively charged Ly-
sine residues in MP-B and the anionic phospholipid of the
cell membrane. MP-B demonstrated strong antimicrobial
activities against both Gram-positive and Gram-negative
pathogens (14). Investigations suggested two E. coli strains,
S. xylosus and Citrobacter koseri at low dosages (0.1 mg/L),
were sensitive to this compound (15). In another study, MP-
B and its analogs were found to be safe to the probiotics af-
ter undergoing appropriate amino acid substitutions (16).
Indolicidin is a cationic antimicrobial peptide isolated
from bovine neutrophils. It has the highest tryptophan
content of any known protein (17). Despite the small
size and unique composition, indolicidin is capable of
killing Gram-negative bacteria by crossing the outer mem-
brane and causing disruption of the cytoplasmic mem-
brane channel formation (18). Jindal et al., (19) evaluated
the microbicidal activity of indolicidin against S. aureus
and E. coli as test organisms. E. coli was more susceptible
to indolicidin.
2. Objectives
The objectives of this study were to evaluate the
antibacterial activity and synergistic effects of the
mastoparan-B, indolicidin, TiO2, and ZnO NPs against
drug- resistant isolates of P. aeruginosa, A. baumannii, and
K. pneumoniae isolated from a referral hospitals in Kerman,
Iran.
3. Methods
3.1. Specimen Collection and Samples Sources
From March to August 2015, we isolated a total of 30
samples (10 each) of antibiotic resistant MDR strains of P.
aeruginosa, K. pneumoniae, and A. baumannii from patients
hospitalized in adult ICUs of two referral hospitals in Ker-
man, Iran. Duplicate samples were collected from each pa-
tient by a laboratory technician. The samples were taken
from the tracheal aspirate, blood, or urine. They were ini-
tially inoculated on MacConkey, Citrimate, and Cysteine
electrolyte deficient (CLED) agar medium and incubated
for 24 h at 37 ºC. The individual colonies were then iden-
tified as P. aeruginosa, K. pneumoniae, and A. baumannii by
biochemical characteristics and conventional diagnostic
tests as described previously (20).
3.2. Antimicrobial Susceptibility Testing
The antibiotic sensitivity of each isolate to 17 antibi-
otics was determined by disk diffusion breakpoint method
as described by the CLSI guideline (21). The zone of inhi-
bition diameter surrounding each disk was measured and
labeled as resistance, intermediate, and sensitive accord-
ing to the manufacturer protocol (Mast group Ltd. UK).
Susceptibility to tigecycline was classified based on the EU-
CAST criteria. The following antibiotics were used in this
study with concentration µg cm-1, tigecycline (TIG, 15), cef-
tazidime (CAZ, 30), imipenem (IMP, 10), meropenem (MEM,
10), amikacin (AK, 30), cefoxitin (CFO, 30), Gentamicin (GM,
30), cefpirome (CPO, 30), fosfomycin (FO, 50), ciprofloxacin
(CIP, 5), ceftizoxime (ZOX, 30), norfloxacin (NOR, 10), and
cefepime (FEP, 30). E. coli ATCC 25922 was used as a control
strain in an antimicrobial susceptibility study.
3.3. Compounds Sources
Synthetic nano-TiO2 (Sigma-Aldrich CAS number 1317-
70-0) and nano-ZnO (Sigma-Aldrich CAS Number: 1314-13-
2) were purchased from the nano-Sany Corporation Ltd.,
(Mashhad, Iran) with the average purity of 99.7% trace
metals basis. The nanoparticles were added into 5 ml
D/W containing 5% of polyethylene glycol (PEG). PEG was
used to disperse the colloidal nanoparticles and was not
inhibitory at this concentration. The nanoparticles were
then homogenized after 30 min of incubation at 37 ºC by
sonication at 100 w, 40 KHz (to disperse the nanoparti-
cle), and the dispersed solutions were autoclaved at 121
ºC for 15 min and kept at 4 °C. The purity of nanometals
was checked by scanning electron microscope (SEM) and X-
ray diffraction (XRD) analysis. Similarly, mastoparan-B and
indolicidin peptides were purchased from BIO BASIC Int.,
(Canada), with the purity of 99%. The peptides purity was
further checked by HPLC and Mass spectroscopy by com-
pany.
3.4. Determination of Bactericidal Activity of Nanometals, and
Synthetic Peptides
Broth microdilution method was used for determina-
tion of MIC and MBC tests according to the CLSI recommen-
dations (22). Briefly, primary stock solution (2560 mg/L) of
each nanoparticle and peptides was prepared and diluted
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in the concentrations ranged from 5 to 2560 mg/L (13). A to-
tal of 50µL of 2-fold serial dilutions of peptides was added
to 96-well microtiter plates containing 50µL of sterile syn-
thetic M9 medium as the source of carbon for metal ox-
ide NPs and Luria -Bertani (LB) broth (Merck, Germany) for
the peptides. We used synthetic M9 medium to avoid pre-
cipitation of nanometals with component of the complex
medium. To this preparation, 50 µL of the bacterial sam-
ple at 1× 106 CFU/mL was added to each well. Prior to this,
the microplates containing two fold dilutions of nano-TiO2
was placed under UV light for 15 min with 10 cm distance
from UV source (antimicrobial peptides did not expose to
UV light). The trays were rolled with aluminum foil and
placed in plastic bags to stop evaporation of water incu-
bated at 37 ºC for 24 h and the turbidity was measured at
650 nm or by the naked eye. MIC was defined as the lowest
concentration of the above compounds that inhibits the
bacterial growth. Simultaneously, a positive control (stan-
dard bacteria) and negative control (without bacterium)
were run along the tests. A loopful of MIC concentration
(no visible growth) was then streaked on Muller-Hinton
agar and checked for colonies after 24 h of incubation at 37
ºC. The number of colonies formed was calculated and con-
sidered as MBC. The MBC was defined as the lowest concen-
tration of nano-TiO2, nano-ZnO, and antibacterial peptides
causing at least 99.9% killing of the initial number of bacte-
ria. The experiment was carried out in triplicate to confirm
the genunity of the results.
3.5. Determination of Antimicrobial Synergism
Checkerboard titration assay was carried out to obtain
the fractional inhibitory concentration (FIC) indexes of
each antimicrobial compound as described before (23). For
this purpose, different concentrations of nano-TiO2, nano-
ZnO, and antimicrobial peptides at sub-MIC level were pre-
pared. A total of 50 µL of chemically defined M9 medium
plus 0.2% glucose (glucose was sterilized by filtration) was
distributed into each microtiter well containing nanomet-
als oxides and sterile LB broth medium for peptides. 50
µL of the first compound of the combination was seri-
ally diluted along the ordinate, while the second was di-
luted along the abscissa. 25 µL of each preparation was
then mixed and placed in microtiter plate wells in differ-
ent combinations. A total of 50 µL of inoculum (CFU/mL 1
× 106) was then added resulting in identical rows. The mi-
croplate containing nano-TiO2 was placed under UV light
for 15 min prior to incubation and one well was kept as con-
trol. After 24 h of incubation at 37 ºC, the turbidity was mea-
sured as described in the above section. The results were
expressed as the FIC, which was determined as follows:
FIC = ([A]/MICA) + ([B]/MICB)
MICA and MICB are the MICs of compound A and com-
pound B alone and [A] and [B] are the MICs of A and B when
in combination. The FIC index was interpreted as follows:
FIC≤ 0.5, synergistic effect; 0.5 < FIC≤ 1, additive effect; 1
< FIC≤ 2, indifferent effect. For calculating synergistic ac-
tion, we used fractional FIC = 0.5 as borderline as described
previously (23).
3.6. Time- Kill Curve Assay
Time-kill curve analyses of P. aeruginosa, K. pneumoniae,
and A. baumannii was performed in dilutions that had the
best FIC index in the checkerboard (24). In brief, 5 mL of
broth was added into four sets of Falcon tubes containing
50 µL of bacterial samples at a 0.5 McFarland inoculum
(106 CFU/mL). The cells were exposed to concentrations of
MIC×1, MIC×2, MIC×4, and MIC× 8 folds for above com-
binations and one set was kept untreated as a control. Bac-
terial growth was then estimating at different time inter-
vals (0, 4, 7 and 24 hours). The lower limit of sensitivity of
colony counts was 100 CFU/mL. The antimicrobial agents
used were considered synergistic at the lowest concentra-
tion that reduced the original inoculum by 3 log10 CFU/mL
(FIC = 0.05) for each of the indicated time.
4. Results
4.1. Antimicrobial Susceptibility
All the isolates were resistant to commonly used an-
tibiotics as shown in Table 1. A. baumannii isolates were
resistant to 11 antibiotics tested, including imipenem,
meropenem, amikacin, cefoxitin, gentamicin, and cef-
pirome, however, all were sensitive to tigecycline, respec-
tively. Overall, we observed that the number of A. bauman-
nii isolates that exhibited resistance to different classes of
antibiotics were more as compared to K. pneumoniae and P.
aeruginosa. Furthermore, K. pneumoniae isolates were resis-
tant to ceftazidime, amikacin, cefotaxime, cefoxitin, gen-
tamicin, cefpirome, ciprofloxacin, and imipenem (Table 1).
4.2. Compounds Characterization
SEM analyses provided evidence that titanium and zinc
aggregates were composed of oxide nanoparticles, spher-
ical shape with size ranges from 20 to 50 nm. Purity was
determined by X-ray diffraction analyses at 60 Kev over the
range of 20 - 80º. Similarly, peptides purities were checked
by HPLC and Mass spectrometer. The data was provided by
nano Sany Company.
Arch Pediatr Infect Dis. 2018; 6(3):e57920. 3
Masoumi S et al.
Table 1. Antibiotic Susceptibility of K. pneumoniae, A. baumannii, and P. aeruginosa Hospital Isolates Against 15 Antibioticsa
Antibiotics
K. pneumonia (No. of Isolates) A. baumannii (No. of Isolates) P. aeruginosa (No. of Isolates)
R I S R I S R I S
TIG 30 0 70 0 10 90 50 10 40
CAZ 100 0 0 100 0 0 100 0 0
IMP 100 0 0 100 0 0 100 0 0
MEM 90 10 0 100 0 0 100 0 0
AK 100 0 0 90 0 10 70 0 30
CFO 100 0 0 ND ND ND ND ND ND
GM 100 0 0 90 0 10 90 10 0
CPO 100 0 0 100 0 0 90 0 10
FO 20 20 60 ND ND ND ND ND ND
CIP 70 10 20 100 0 0 100 0 0
ZOX 100 0 0 ND ND ND 100 0 0
NOR 60 20 20 ND ND ND ND ND ND
FEP 80 20 0 100 0 0 ND ND ND
AZT ND ND ND 100 0 0 90 0 10
PTZ ND ND ND 100 0 0 80 10 10
Abbreviations: AK, amikacin; CAZ, ceftazidime; CFO, cefoxitin; CPO, cefpirome; CIP, ciprofloxacin; FO, Fosfomycin; FEP, cefepime; GM, gentamicin; TIG, tigecycline; IMP,
imipenem; I, intermediate; MEM, meropenem; NOR, norfloxacin; ND, not determined; R, resistance; S, sensitive; ZOX, ceftizoxime.
aAntibiotic sensitivity was determined in Muller-Hinton agar with inoculum concentration 1×106 CFU/ml.
4.3. Antibacterial Activity of the Mastoparan-B, Indolicidin, ZnO
NPs and TiO2 NPs
MP-B induced broad-spectrum bactericidal effect on A.
baumannii, K. pneumoniae, and P. aeruginosa MDR isolates
tested and inhibited the growth at mean MIC concentra-
tion 4 ± 0.2 mg/L; in contrast, no growth inhibition was
detected for TiO2 NPs (MIC≥ 1280±0.2 mg/L) (Table 2). We
also screened peptides and nano metals for toxicity against
P. aeruginosa isolates. All isolates were resistant to TiO2 NPs
and showed MIC ≤ 2560 mg/L. We observed that P. aerug-
inosa was less susceptible to mastoparan and indolicidin
as compared to A. baumannii and K. pneumoniae with MIC
64 mg/mL (Table 2). From a susceptibility point of view, A.
baumannii was more susceptible to the above antimicro-
bial agents than other bacterial species tested.
4.4. Synergism and Time-Kill Curves Analysis
Checkerboard titration method revealed that both the
nano-TiO2 and nano-ZnO NPs had an additive but not syn-
ergistic effect against A. baumannii and K. pneumoniae iso-
lates (FIC = 1± 0.2), while P. aeruginosa isolates were indif-
ference to the combination of these compounds (FIC ≤ 2
± 0.1) (Table 3). Furthermore, four isolates of A. baumannii,
four isolates of K. pneumoniae, and two isolates of P. aerug-
inosa were selected for time-kill analysis. We observed that
rapid killing of these isolates occurred at 4 h of the assay.
MP-B and the indolicidin combination had the synergistic
activity against A. baumannii, K. pneumoniae, and P. aerug-
inosa isolates (FIC = 0.5 ± 0.2). The data presented in Ta-
ble 3 showed two isolates of A. baumannii, three isolates of
K. pneumoniae, and four isolates of P. aeruginosa exhibited
FIC≤ 0.37 (three fold decreases in log10 CFU/mL), however,
nanoparticles exerted an additive effect within the assay
time of 4 h incubation (Figure 1). The nano-TiO2 and nano-
ZnO combination was more effective against K. pneumoniae
as compared to other isolates, however, little bactericidal
activity against A. baumannii. Furthermore, MP-B and in-
dolicidin combination had biocidal activities on all bacte-
rial isolates tested and drastically reduced viable counts of
above species at 4 and 7 h of incubations (Figure. 1).
5. Discussion
With different types of antibiotic resistance genes and
acquisition of plasmids spread, transposons and integrons
among hospital isolates of A. baumannii, P. aeruginosa, and
K. pneumoniae, as well as ever increasing failure in treat-
ment of patients due to lack of proper treatment options,
we decided to evaluate the susceptibility and synergistic ef-
fect of MP-B, indolicidin, nano-TiO2, and nano-ZnO as sub-
stitutes to antibiotics. Mastoparan-B peptide was the most
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Table 2. Comparison Antimicrobial Activity of Mastoparan-B, Indolicidin and Nano-Metal Oxides Against MDR Strains of A. baumannii, K. pneumoniae, and P. aeruginosa Isolated
from Clinical Samplesa
Isolate No.
Mastoparan-B Indolicidin Nano-Tio2 Nano-ZnO
MIC MBC MIC MBC MIC MBC MIC MBC
AB
1 4 4 16 16 640 640 80 80
2 4 4 8 32 640 640 80 80
3 4 8 16 16 320 320 40 80
4 4 4 32 32 640 640 160 320
5 4 4 16 16 640 640 320 320
6 16 32 32 64 1280 1280 80 80
7 4 4 16 16 1280 1280 80 80
8 4 4 32 32 640 1280 320 320
9 2 2 8 16 320 320 40 80
10 4 4 16 32 640 640 80 80
KP
1 8 8 64 64 1280 1280 160 160
2 8 16 32 32 1280 1280 160 160
3 16 16 32 64 2560 2560 640 640
4 8 8 32 32 1280 1280 160 160
5 16 32 64 64 640 1280 320 320
6 8 8 32 32 1280 1280 80 160
7 8 8 32 64 1280 1280 320 320
8 8 8 64 64 2560 2560 640 640
9 4 4 32 32 1280 1280 160 160
10 4 4 32 32 640 640 160 160
PS
1 32 32 64 128 ≥ 2560 ND 2560 2560
2 32 32 64 64 ≥ 2560 ND 2560 2560
3 64 64 128 128 ≥ 2560 ND ≥2560 ND
4 32 64 64 64 ≥ 2560 ND 1280 1280
5 64 64 128 128 ≥ 2560 ND 2560 2560
6 128 128 128 256 ≥ 2560 ND ≥2560 ND
7 32 32 64 64 ≥ 2560 ND 2560 2560
8 32 32 128 128 ≥ 2560 ND ≥2560 ND
9 64 64 128 128 ≥ 2560 ND 1280 1280
10 32 64 64 64 ≥ 2560 ND 2560 2560
Abbreviations: AB, A. baumannii; KP, K. pneumonia; MIC, mg/mL; MBC, mg/mL; ND, not determined; PS, P. aeruginosa.
aSterile M9 medium containing glucose as the source of carbon was used for metal oxide NPs and LB broth was used for peptides MIC determinations. MICs were
performed in triplicate with a standard deviation of± 0.2. Bacterial sample was used at 1× 106 CFU/mL.
potent biocide effective against A. baumannii, P. aeruginosa,
and K. pneumoniae isolates (average MIC 4 mg/L), while in-
dolicidin exerted bactericidal activity at higher MIC con-
centrations (MIC 16 mg/L), respectively. Furthermore, our
findings suggest that the high MIC values of Tio2 and ZnO
NPs may be related to a decrease in porosity of Gram- neg-
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Table 3. Checkerboard Results of Number of Isolates Showing the Synergisms When Exposed to Nanoparticles and Antimicrobial Peptides Combinationsa
Nanoparticles and Peptides Number of Isolate
FICs
0.18 0.25 0.31 0.37 0.5 0.53 0.56 0.62 0.75 1.0
A. baumannii TiO2+ZnO 7 - - 1 3 3 1 3 5 3 1
K. pneumonia TiO2+ZnO 5 - - 1 2 2 2 3 6 4 -
A. baumanniiMP + Indolicidin 3 - - - 2 1 - - 5 6 1
K. pneumoniaeMP + Indolicidin 6 - - - 3 3 - 1 3 4 1
P. aeruginosaMP + Indolicidin 12 2 2 4 1 3 4 2 4 - 1
Abbreviations: FICs, Fractional inhibitory concentration indexes; MP, Mastoparan-B; Indo, Indolicidin.
aThe above values are in mg/mL. M9 containing glucose as source of carbon was used for nanometals and LB broth was used for peptides. 0.5≤ synergism, 0.5-1 = additive,
1- 4 = indifference, 4≥ antagonism. The results were repeated three times and similar observation was made. P≤ 0.5 was considered statistically significant.
Time, h Time, h
Time, h
Lo
g1
0
[C
FU
/m
L]
Lo
g1
0
[C
FU
/m
L]
Lo
g1
0
[C
FU
/m
L]
Control
MP-B + Indolicidin 
Nano-TiO2+Nano-ZnO 
Control
MP-B + Indolicidin 
Nano-TiO2+Nano-ZnO 
Control
MP-B + Indolicidin 
Nano-TiO2+Nano-ZnO 
10
9
8
7
6
5
4
3
2
1
0
10
9
8
7
6
5
4
3
2
1
0
10
9
8
7
6
5
4
3
2
1
0
0                                   4                                     7                                   24 0                       4                          7                        24
0                            4                                7                               24
A. baumannii K. pneumoniae 
P. aeruginosa 
Figure 1. Time-kill curves assay of mastoparan-B and indolicidin as compared to nano-TiO2 and nano- ZnO combinations for MDR strains of A. baumannii and K. pneumoniae
and P. aeruginosa. Data from triplicate experiments are presented as means± SEM.
ative cell wall or existence of eﬄux pump that causes a de-
crease in intracellular concentrations of these compounds
resulted in drastic reduction on biocidal activity of these
compounds, even though we used synthetic medium to
avoid precipitation of nanometals in the medium. The re-
sults were further supported by using combination of TiO2
and ZnO NPs that showed an additive effect on most of
the A. baumannii and K. pneumoniae isolates (two fold de-
creases in log10 CFU/mL) but did not inhibit the growth
of P. aeruginosa. However, synergism was observed when
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mastoparan-B and indolicidin combination were used at
sub-MIC values by checker board titration tests. This is very
interesting since the majority of burn infections caused
by these microorganisms are resistant to carbapenem and
make treatment very difficult.
It has been shown that the addition of ZnO NPs and
TiO2 NPs generate reactive oxygen, causing an oxidative
stress and bacterial cell death (25). Similarly, Khan et al.,
(25) reported that, ZnO and TiO2 NPs inhibited the growth
and biofilm formation of the Streptococcus mitis ATCC 6249
at very low concentration. They suggested that ZnO and
TiO2 NPs can be used as alternative antimicrobial agents
for oral hygiene. Furthermore, recent investigation sug-
gested that Campylobacter jejuni, the most common food-
borne pathogen, was extremely sensitive to ZnO nanopar-
ticles and the MIC for C. jejuni was determined to be 0.05 to
0.025 mg/mL, which was found to be 8 to 16 fold lower than
that for Salmonella enterica Enteritidis and E. coli O157:H7
(0.4 mg/mL) (26).
The synergistic effect of the MP-B and indolicidin com-
bination was further observed by time-kill assay. The re-
sults revealed that, at the sub-MIC concentrations, MP-B
and indolicidin combination rapidly killed antibiotic re-
sistant isolates, especially P. aeruginosa (reduced three-
fold in log10 CFU/mL of the isolates), whereas, TiO2 +
ZnO nanoparticles had practically no effect on these iso-
lates alone, however, it virtually exerted an additive effect
within 4 h incubation against certain isolates of A. bau-
mannii and K. pneumoniae hospital isolates when used in
combination but not P. aeruginosa strains. This finding is
consistent with previous data (27) and demonstrates ob-
served bactericidal effect against both Gram-positive and
Gram-negative MDR bacteria over a 7 h incubation pe-
riod when treated with sub-inhibitory concentrations of
oregano essential oil and Ag NPs. Similar to our exper-
iments, Vila-Farres et al., (28) found that, among 15 an-
timicrobial peptides tested, indolicidin and mastoparan
showed good activity against both colistin-susceptible and
colistin-resistant A. baumannii.
5.1. Conclusion
Our results suggest that antibacterial peptides MP-B
and indolicidin in combination had a synergistic effect
and may be a suitable candidate for antibiotics in treat-
ment of topical infections associated with above bacteria.
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